{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:35:53Z","timestamp":1759541753449},"reference-count":11,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":9391,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1982,7]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We have tested the hypothesis that physiological puerperal hyperprolactinaemia may be secondary to reduced hypothalamic dopaminergic inhibition of prolactin (PRL) release. Nine post\u2010partum females with physiological hyperprolactinaemia (aged 19\u201340 years; mean basal PRL\u00b1SE, 2099\u00b1257 mU\/l, range 1002\u20133762 mU\/l) were studied and results compared with fourteen normoprolactinaemic females (basal PRL&lt;400 mU\/l; aged 18\u201336 years). Puerperal hyperprolactinaemic females showed a reduced TSH response to dopamine (DA) receptor blockade with metoclopramide (10 mg i.v.) compared with normal females over a 60\u2010min period following drug administration (total incremental TSH change, mean \u00b1SE, mU\/l; 0.5\u00b10.3 v. 3.1\u00b11.0, <jats:italic>P<\/jats:italic>&lt;0.005). This finding of reduced dopaminergic inhibition of TSH release in females with physiological puerperal hyperprolactinaemia supports the view that an overall reduction in hypothalamic dopaminergic tone may contribute towards hyperprolactinaemia in post\u2010partum women.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1982.tb02629.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T13:02:18Z","timestamp":1205758938000},"page":"15-19","source":"Crossref","is-referenced-by-count":7,"title":["REDUCED DOPAMINERGIC INHIBITION OF THYROTROPHIN RELEASE IN STATES OF PHYSIOLOGICAL HYPERPROLACTINAEMIA"],"prefix":"10.1111","volume":"17","author":[{"given":"MARIA D.","family":"RODRIGUEZ\u2010ARNAO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"WEIGHTMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"REGINALD","family":"HALL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURICE F.","family":"SCANLON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"CAMPORRO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"GOMEZ\u2010PAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-155-39852"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-105-3-636"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000121887"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5749.582"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000122042","article-title":"Effect of prolactin and ergot alkaloids in the tubero\u2010infundibular dopamine (DA) neurons","volume":"4","author":"Hokfelt T.","year":"1972","journal-title":"Neuroendocrinology"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)33237-3"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350424"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb03028.x"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00608.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-475360-0.50019-5"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000122557"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1982.tb02629.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1982.tb02629.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T17:46:26Z","timestamp":1699724786000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1982.tb02629.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,7]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,7]]}},"alternative-id":["10.1111\/j.1365-2265.1982.tb02629.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1982.tb02629.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,7]]}}}